SPECTA is EORTC pan-European translational research platform, created to promote development of TR projects in Europe, mainly focusing on the biological aspects of cancer, including molecular profiling and personalized therapy.

Several projects are currently in the pipeline, either recruiting patients (IMMUcan and Arcagen), in the final analysis step (AYA), in activation (BioRadon) or in development.

If you are interested in developing a project with us, please reach out to specta@eortc.org